Junex Inc. JNEXF Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Junex Inc. JNEXF Company Overview 

Stock Message Board http://investorshangout.com/search?q=JNEXF&am...mp;yt1=Go!

Junex Inc. JNEXF Current Price and Quotes
Last Price 0.597
Previous Close 0.597 Open N/A
Daily Range N/A - N/A 52wk Range 0.80 - 0.44
Volume 0 Dividend N/A
Average Vol (3m) 2,239 Yield N/A
Junex Inc. JNEXF
Company Information

2795 boulevard Laurier
Suite 200
Quebec, QC G1V 4M7
Canada

Website: http://www.junex.ca
Phone: 418-654-9661
Email: junex@junex.ca

Junex Inc. JNEXF
Junex Inc. JNEXF
Financial Reportings and Disclosures

Reporting Status Dark: Alternative Reporting Standard
Fiscal Year End Not Available
OTC Marketplace Grey Market
Profile Data

SIC - Industry Classification
Incorporated In: Quebec, Canada
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Not Available
Company Directors

Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Junex Inc. JNEXF
JNEXF Security Details

Share Structure

Market Value1 $36,111,378 a/o Sep 05, 2013
Shares Outstanding 60,488,070 a/o Nov 30, 2011
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Non US Stock Exchange Listing

JNX - TSX Venture Exchange - Qualified
Short Selling Data

Short Interest 0 (-100%)
Jan 30, 2009
Significant Failures to Deliver  No
Transfer Agent(s)

Computershare Trust Company of Canada Inc.

Junex Inc. JNEXF Recent News

Junex Inc. JNEXF Financials
Data is unavailable at this time. Please check this page later.


JNEXF Junex Inc. Research DD Guide

JNEXF Junex Inc. Stock Message Board http://investorshangout.com/search?q=JNEXF&am...mp;yt0=Go!
JNEXF Junex Inc. Stock Quote http://www.otcmarkets.com/stock/JNEXF/quote
JNEXF Junex Inc. Stock Chart http://www.otcmarkets.com/stock/JNEXF/chart
JNEXF Junex Inc. Company Info http://www.otcmarkets.com/stock/JNEXF/company-info
JNEXF Junex Inc. Recent News http://www.otcmarkets.com/stock/JNEXF/news
JNEXF Junex Inc. Financials http://www.otcmarkets.com/stock/JNEXF/financials
JNEXF Junex Inc. Filings and Disclosure http://www.otcmarkets.com/stock/JNEXF/filings
JNEXF Junex Inc. Short Sales http://www.otcmarkets.com/stock/JNEXF/short-sales
JNEXF Junex Inc. Insider Disclosure http://www.otcmarkets.com/stock/JNEXF/insider-transactions
JNEXF Junex Inc. Research Reports http://www.otcmarkets.com/stock/JNEXF/research
JNEXF Junex Inc. Summary http://finance.yahoo.com/q?s=JNEXF
JNEXF Junex Inc. Historical Prices http://finance.yahoo.com/q/hp?s=JNEXF+Historical+Prices
JNEXF Junex Inc. Interactive Chart http://finance.yahoo.com/echarts?s=JNEXF
JNEXF Junex Inc. Basic Chart http://finance.yahoo.com/q/bc?s=JNEXF+Basic+Chart
JNEXF Junex Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=JNEXF+Basic+Tech.+Analysis
JNEXF Junex Inc. Headlines http://finance.yahoo.com/q/h?s=JNEXF+Headlines
JNEXF Junex Inc. Press Releases http://finance.yahoo.com/q/p?s=JNEXF+Press+Releases
JNEXF Junex Inc. Company Profile http://finance.yahoo.com/q/pr?s=JNEXF+Profile
JNEXF Junex Inc. Key Statistics http://finance.yahoo.com/q/ks?s=JNEXF+Key+Statistics
JNEXF Junex Inc. Industry http://finance.yahoo.com/q/in?s=JNEXF+Industry
JNEXF Junex Inc. Major Holders http://finance.yahoo.com/q/mh?s=JNEXF+Major+Holders
JNEXF Junex Inc. Insider Transactions http://finance.yahoo.com/q/it?s=JNEXF+Insider+Transactions
JNEXF Junex Inc. Insider Roster http://finance.yahoo.com/q/ir?s=JNEXF+Insider+Roster
JNEXF Junex Inc. Income Statement http://finance.yahoo.com/q/is?s=JNEXF
JNEXF Junex Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=JNEXF
JNEXF Junex Inc. Cash Flow http://finance.yahoo.com/q/cf?s=JNEXF+Cash+Flow&annual
JNEXF Junex Inc. Nasdaq http://www.nasdaq.com/symbol/JNEXF
JNEXF Junex Inc. Market Watch http://www.marketwatch.com/investing/stock/JNEXF
JNEXF Junex Inc. Bloomberg http://www.bloomberg.com/quote/JNEXF:US
JNEXF Junex Inc. Morningstar http://quotes.morningstar.com/stock/s?t=JNEXF
JNEXF Junex Inc. Bussinessweek http://investing.businessweek.com/research/st...cker=JNEXF
JNEXF Junex Inc. Barchart http://www.barchart.com/quotes/stocks/JNEXF
JNEXF Junex Inc. OTC Short Report http://otcshortreport.com/index.php?index=JNEXF
JNEXF Junex Inc. Investopedia http://www.investopedia.com/markets/stocks/JNEXF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading